Amlodipine/celecoxib
Amlodipine/celecoxib, sold under the brand name Consensi, is a medication used to treat osteoarthritis in adults.[1] It is a fixed-dose combination of amlodipine besylate and celecoxib.[1] It is taken by mouth.[1]
| Combination of | |
|---|---|
| Amlodipine | Calcium channel blocker |
| Celecoxib | Nonsteroidal anti-inflammatory drug (NSAID) |
| Clinical data | |
| Trade names | Consensi |
| AHFS/Drugs.com | Professional Drug Facts |
| License data | |
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | |
| UNII | |
| KEGG | |
The most common side effects include edema, abdominal pain, diarrhea, dyspepsia, flatulence, peripheral edema, accidental injury, dizziness, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, and rash.[1]
It was approved for use in the United States in May 2018.[2]
Medical uses
Amlodipine/celecoxib is indicated for use in adults for whom treatment with amlodipine for hypertension and celecoxib for osteoarthritis are appropriate.[1]
History
Amlodipine/celecoxib was approved for use in the United States in May 2018.[2]
References
- "Consensi- amlodipine besylate and celecoxib tablet". DailyMed. 17 December 2019. Retrieved 14 May 2020.
- "Drug Approval Package: Consensi (amlodipine and celecoxib)". U.S. Food and Drug Administration (FDA). 29 November 2018. Retrieved 14 May 2020.
External links
- "Amlodipine mixture with celecoxib". Drug Information Portal. U.S. National Library of Medicine.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.